Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-10-15
著者
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAMATA Noriko
Department of Radiology, Tokyo Metropolitan Komagome Hospital
-
Sakamaki H
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Sakamaki Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Asaoku Hideki
Clinical Laboratory Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital
-
Yamashita Takuya
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
Oshimi Kazuo
Division Of Hematology Department Of Internal Medicine Juntendo University School Of Medicine
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Oshimi Kazuo
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Sanaka Masaki
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Kamata Noriko
Department Of Gastroenterology Osaka City University Graduate School Of Medicine
-
Kamata Noriko
Radiology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Sanaka Masaki
Department Of Preventive Medicine Medical Research Institute Tokyo Medical And Dental University
-
Oshimi Kazuo
Department Of Hematology Juntendo University Tokyo
-
Sakamaki Hisashi
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Yamashita Takuya
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Akiyama Hideki
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Akiyama H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Akiyama Hideki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Akiyama Hideki
Department Of Civil And Ocean Engineering Faculty Of Engineering Ehime University
-
SAKAI Miwa
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
OHTA Keiko
Neurology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KISIDA Shuji
Neurology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
Sakamaki H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Ohashi Kazuteru
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kisida Shuji
Neurology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Ohta Keiko
Neurology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Sakamaki Hisashi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Asaoku Hideki
Internal Medicine Hiroshima Red Cross Hospital
-
Yamaguchi Toshikazu
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Amano Hiroki
Department Of Public Health Shimane University Faculty Of Medicine
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Primary Sclerosing Cholangitis Complicated with Idiopathic Thrombocytopenic Purpura
- Rapidly Progressive Epstein-Barr Virus-associated Lymphoproliferative Disorder Unpredictable by Weekly Viral Load Monitoring
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)